1-4 of 4
Juergen Bader
Close
Sort by
Journal Articles

Defining the Most Effective Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors

Andrej Besse, Lenka Besse, Marianne Kraus, Juergen Bader, Gerjan de Bruin, Herman S Overkleeft, Christoph Driessen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5388.
https://doi.org/10.1182/blood.V130.Suppl_1.5388.5388
Published: 2017
Journal Articles

Nelfinavir Blocks Export of Newly Synthesized Protein from the ER and Interacts with ER-Resident and Mitochondrial Proteins in an Activity-Dependent Fashion

Andrej Besse, Lenka Besse, Sara C. Stolze, Marianne Kraus, Juergen Bader, Herman S Overkleeft, Christoph Driessen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3074.
https://doi.org/10.1182/blood.V130.Suppl_1.3074.3074
Published: 2017
Journal Articles

The First in Class, Alkylator-Histone-Deacetylase-Inhibitor Fusion Molecule Edo-S101 in Combination with Proteasome Inhibitors Induces Highly Synergistic Pro-Apoptotic Signaling through UPR Activation and Suppression of c-Myc and BCL2 in Multiple Myeloma

Lenka Besse, PhD, Marianne Kraus, PhD, Andrej Besse, Juergen Bader, Thomas Mehrling, MD PhD, Christoph Driessen, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4466.
https://doi.org/10.1182/blood.V128.22.4466.4466
Published: 2016
Journal Articles

Proteasome Inhibitor-Adapted Myeloma Cells That Lack Proteasome Gene Mutations Resist Highly Efficient Proteasome Inhibition and Show Proteomic Alterations That Suggest Complex Metabolic Changes

Lenka Besse, PhD, Guillem Soriano, Nan Li, Andrej Besse, Marianne Kraus, Juergen Bader, Tobias Christian Silzle, MD, Nico Meeuwenoord, Hans den Dulk, Herman S Overkleeft, Bogdan Florea, Christoph Driessen, MD
Journal: Blood
Blood (2015) 126 (23): 1278.
https://doi.org/10.1182/blood.V126.23.1278.1278
Published: 2015